Form 8-K - Current report:
SEC Accession No. 0001104659-25-054131
Filing Date
2025-05-29
Accepted
2025-05-29 13:46:56
Documents
13
Period of Report
2025-05-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516491d1_8k.htm   iXBRL 8-K 70136
  Complete submission text file 0001104659-25-054131.txt   313884

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrk-20250527.xsd EX-101.SCH 4655
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20250527_def.xml EX-101.DEF 29174
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20250527_lab.xml EX-101.LAB 39688
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20250527_pre.xml EX-101.PRE 27658
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2516491d1_8k_htm.xml XML 11323
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 251001171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)